Introduction

Clinical orthopedic treatment such as immobilization and/or unloading (non-weight-bearing by cast and crutches) induces muscle atrophy and a decline in muscle function in the lower limb [1, 2]. For instance, cast immobilization (CIM), which stabilizes the ankle and knee angle, is required for a few weeks or months to treat a sprain, fracture, and/or ligament injury, with crutches frequently used for ambulatory activities of daily living (ADLs). Several studies have shown 5–20% decreases in the cross-sectional area (CSA) of knee extensor muscle resulting from muscle disuse and/or unloading for a few weeks [3,4,5,6]. Muscle use and loading of one’s body weight to antigravity muscles is important to maintain the skeletal muscles’ quantity, function, and metabolism [3, 5, 7, 8].

With the decrease in muscle quantity, adipose tissue infiltrates into and/or between muscles. Excessive accumulation of this type of adipose tissue has been frequently confirmed in the presence of disused legs of patients with spinal cord injury and stroke-related hemiparetic patients [9,10,11]. Based to the location of adipose tissue accumulation, these tissues are usually categorized into two types: Adipose tissue that has infiltrated “into” the muscle is known as intramuscular adipose tissue (IntraMAT), and the adipose tissue that accumulates “between” muscles is known as intermuscular adipose tissue (InterMAT) [12,13,14,15]. Gorgey and Dudley [10] reported that the IntraMAT content in the thighs of patients with spinal cord injury was twice as high as that in able-bodied controls. Increased IntraMAT and InterMAT in the thigh could have negative effects on knee extension strength, mobility, and/or physical performance [14, 16]. The infiltration of adipose tissue into muscle is negatively associated with glucose metabolism [16,17,18], eventually inducing type 2 diabetes. Taken together, the information on changes in IntraMAT and InterMAT resulting from orthopedic treatment would be crucial for understanding a deteriorating quality of skeletal muscle metabolic impairment. It is unclear, however, whether the changes in IntraMAT and InterMAT were linked to the change in muscle size during acute longitudinal clinical observation.

The purpose of this study was to assess how clinical CIM affected IntraMAT, InterMAT, and skeletal muscle tissue in the thigh and calf muscles. We hypothesized that IntraMAT and InterMAT might increase along with the decrease in skeletal muscle tissue quantity after 4 weeks of orthopedic treatment in the clinical setting.

Materials and methods

Experimental procedure

We targeted patients who came to the Akita Hospital for external injuries (i.e., fracture of the ankle mortise, fifth metatarsal bone, or fibula; Table 1). The subjects’ ankle joints were fixed by plaster cast for approximately 4 weeks. The average CIM duration was 26 ± 1 days. The first magnetic resonance imaging (MRI) scan was acquired at the earliest opportunity following surgery. During CIM, subjects managed their ambulant ADLs on crutches, with the injured leg maintained unloaded (non-weight-bearing). The second MRI scan was acquired when the cast was removed. All patients then started rehabilitation.

Table 1 Clinical characteristics of subjects

Subjects

Eight patients with a fracture of the fifth metatarsal bone or fibula participated in this study (mean age 59.8 ± 5.2 years; height 160.2 ± 3.2 cm; weight 63.5 ± 3.3 kg; body mass index 24.8 ± 1.1 kg/m2; Table 1). Before the experiment, the purpose, procedures, and risks associated with this study were explained to each patient, and written informed consent was obtained from each. All examination protocols were approved by the ethics committees of the Research Center of Health, Physical Fitness, and Sports at Nagoya University and Akita Hospital. The study was conducted in accordance with the ethical principles stated in the Declaration of Helsinki.

Magnetic resonance imaging

Before MRI scanning, subjects were placed in a supine position for 20 min to avoid fluid shifts. Then, to determine the coronal and sagittal femoral bone axis, the coronal slices were obtained using a locater system scout scan (TR/TE = 185/15 ms, field of view = 400 mm, 128 × 256 matrix) using a 1.5-T whole-body MRI scanner (Excel ART; Toshiba, Tokyo, Japan). T1-weighted spin-echo transaxial images of the injured leg were collected with the following parameters: TR/TE = 625/15 ms, field of view = 250 mm, matrix = 512 × 512, slice thickness = 10 mm, interslice gap = 0 mm. MRI measurements were performed before fixing the fracture using a plaster cast and just after removing the plaster cast.

Analysis of thigh and calf composition

Medical Image Processing, Analysis, and Visualization software (version 4.4.0; National Institutes of Health, Bethesda, MD, USA) was used to analyze images on a personal computer (iMac; Apple, Cupertino, CA, USA). The procedure for MRI data analysis was essentially identical to that described previously [19, 20]. Briefly, we assessed the images of the mid-thigh and 30% of the proximal calf. Mid-thigh was defined according to markers attached at the mid-point between the greater trochanter and the lateral condyle. The calf image was from the marker attached 30% proximally, between the lateral condyle and the fibular lateral malleolus. These anatomical markers were determined by palpation. After obtaining the transaxial images, we identified the thigh’s quadriceps femoris (QF: sum of the rectus femoris, vastus lateralis, vastus intermedius, and vastus medialis muscles), hamstring (HM: sum of the biceps femoris short and long head, semitendinosus, and semimembranosus muscles), and adductor (AD: sum of the sartorius, gracilis, adductor longus, and adductor magnus muscles). We also identified four compartments of the calf: the anterior compartment (including the tibial anterior, extensor digitorum longus, and extensor halluces); lateral compartment (peroneus); deep posterior compartment (including the tibial posterior, flexor hallucis longus, and flexor digitorum longus); superficial posterior compartment (including the soleus and medial and lateral gastrocnemius muscles) (Fig. 1c, f).

Fig. 1
figure 1

Representative T1-weighted MRI of the thigh (ac) and the calf (df) before and after cast immobilization. Individual muscles were determined based on the epimysium (c, f). Quadriceps femoris consisted of the rectus femoris (RF), vastus lateralis (VL), vastus medialis (VM), and vastus intermedius (VI) muscles. Hamstrings consisted of the biceps femoris short-head and long-head (BFs and BFl), semitendinosus (ST), and semimembranosus (SM) muscles. The adductor group consisted of the sartorius (Sar), gracilis (Gr), adductor longus (AL), and adductor magnus (AM) muscles. The anterior compartment consisted of the tibial anterior (TA), extensor digitorum longus (EDL), and extensor hallucis longus (EHL) muscles. The lateral compartment consisted of the peroneus (PE). The deep posterior calf consisted of the tibial posterior (TP), flexor hallucis longus (FHL) and flexor digitorum longus (FDL) muscles. The superficial posterior consisted of the soleus (SOL) and gastrocnemius medial head and lateral head (MG and LG) muscles. We also traced the femur (Fe), tibia (TI), and fibula (FI). Scale bar = 5 cm

The methodology for determining the thigh and calf composition was identical to that applied by the authors in previous investigations, which used a well-established, non-parametric, non-uniform intensity normalization (N3) algorithm to correct for image heterogeneity due to suboptimal radiofrequency coil uniformity and gradient-driven eddying currents [19,20,21]. This step was essential for subsequent analyses, which assumed homogeneous signal intensity across images. Optimized image correction parameters were determined (end tolerance 0.0001; maximum iterations 100; signal threshold 1; field distance 25 mm; subsampling factor 2; kernel full-width half-maximum 0.15; Wiener filter noise 0.01), and the same parameters were applied to all images from all participants. The investigator then drew six regions of interest (ROIs) of 5 × 5 mm each. Three ROIs were placed on the vastus intermedius for the thigh and the anterior tibia for the calf. The other three ROIs were placed on subcutaneous adipose tissue. The vastus intermedius and tibial anterior comprise 93 and 99% of skeletal muscle respectively, and were chosen so we would obtain a nearly pure skeletal muscle peak on the pixel number–signal intensity histogram. The total number of pixels within the six ROIs and a frequency distribution and histogram of all pixels and signal intensities were produced.

We measured the IntraMAT CSAs, InterMAT CSAs, IntraMAT contents, and skeletal muscle tissue CSAs of the thigh and calf. To ensure minimal investigator bias in the separation of skeletal muscle and adipose tissue in the pixel number–signal intensity histogram, we used the Otsu threshold method, a reliable histogram shape-based thresholding technique used for medical image analyses [22]. To minimize manual tracing-induced errors on thresholding values, the mean of five trials was used, and the values were applied to all muscles of interest for each subject. After carefully tracing the edge of each muscle group, the following parameters were calculated:

  1. 1.

    The number of pixels with a signal intensity lower than the threshold value (skeletal muscle pixel numbers).

  2. 2.

    The number of pixels with a value higher than the threshold (IntraMAT pixel numbers).

  3. 3.

    The number of pixels at the subfascial level and between the muscles with a value higher than the threshold value (InterMAT pixel number.

The IntraMAT CSA and skeletal muscle tissue CSA were calculated using the following equations (FOV = field of view):

$$ {\displaystyle \begin{array}{l}\mathrm{IntraMAT}\ \mathrm{CSA}\ \left({\mathrm{cm}}^2\right)=\left(\mathrm{IntraMAT}\ \mathrm{pixel}\ \mathrm{number}\right)\times {\left(\mathrm{FOV}/\mathrm{matrix}\ \mathrm{size}\right)}^2\\ {}\mathrm{Skeletal}\ \mathrm{muscle}\ \mathrm{tissue}\ \mathrm{CSA}\ \left({\mathrm{cm}}^2\right)=\left(\mathrm{skeletal}\ \mathrm{muscle}\ \mathrm{pixel}\ \mathrm{number}\right)\times {\left(\mathrm{FOV}/\mathrm{matrix}\ \mathrm{size}\right)}^2\end{array}} $$

Subsequently, the IntraMAT content of each muscle was calculated using the following equation:

$$ \mathrm{IntraMAT}\ \mathrm{content}\left(\%\right)=\left(\mathrm{IntraMAT}\ \mathrm{CSA}\right)/\left[\left(\mathrm{skeletal}\ \mathrm{muscle}\ \mathrm{tissue}\ \mathrm{CSA}\right)+\left(\mathrm{IntraMAT}\ \mathrm{CSA}\right)\right]\times 100 $$

The InterMAT CSA was calculated using the following equation:

$$ \mathrm{InterMAT}\ \mathrm{CSA}\ \left({\mathrm{cm}}^2\right)=\left(\mathrm{InterMAT}\ \mathrm{pixel}\ \mathrm{number}\right)\times {\left(\mathrm{FOV}/\mathrm{matrix}\ \mathrm{size}\right)}^2 $$

The images were read in random order, with one investigator (AY) performing all image analyses. Test–retest reliability of IntraMAT content was reported elsewhere [19, 20]. Briefly, we determined the intraclass correlation coefficient (ICC 2.1) for the IntraMAT and InterMAT, which ranged from 0.61 (IntraMAT of the hamstrings) to 0.99 (IntraMAT of the anterior compartment) (p < 0.01).

Statistical analysis

All values are reported as means ± standard error (SE). Wilcoxon signed-rank test was used to compare variables after clinical orthopedic treatment for the IntraMAT, InterMAT, and skeletal muscle tissue CSAs in the thigh and calf. We further compared these variables in each muscle group for the thigh and calf (QF, HM, AD: i.e., each compartment of the calf). The percentage changes per day for the IntraMAT CSA and skeletal muscle tissue CSA in all muscle groups were compared using the Kruskal–Wallis test. We used the Mann–Whitney test to compare the percentage changes per day for the IntraMAT and InterMAT CSAs in the thigh and calf. Spearman’s rank correlation was used to determine the association between the percentage changes per day for the IntraMAT, InterMAT, and skeletal muscle tissue CSAs. The level of significance was set at p < 0.05. All statistical analyses were performed using IBM SPSS statistics software (version 22.0 J; IBM Japan, Tokyo, Japan).

Results

The IntraMAT, InterMAT, and skeletal muscle tissue CSAs before and after the orthopedic treatment are shown in Table 2. The IntraMAT and InterMAT CSAs did not change throughout the intervention. Skeletal muscle tissue CSAs in the whole thigh, QF region, superficial posterior compartment of the calf, and whole calf significantly decreased after treatment. IntraMAT content in the anterior compartment of the calf significantly increased after the treatment. The percentage changes per day of the IntraMAT CSA and skeletal muscle tissue CSA were compared among muscle regions, with no significant differences found (Fig. 2).

Table 2 Intramuscular adipose tissue cross-sectional area (IntraMAT CSA), skeletal muscle tissue CSA, IntraMAT content, and intermuscular adipose tissue CSA (InterMAT CSA) before and after cast immobilization
Fig. 2
figure 2

Percentage changes in the IntraMAT CSA and skeletal muscle tissue CSA in each muscle group of the thigh and calf. Values are means ± standard error (SE). IntraMAT intramuscular adipose tissue, CSA cross-sectional area

Figure 3 shows the percentage changes per day of the IntraMAT and InterMAT CSAs in the thigh and calf. There was no significant difference in the percentage changes between the IntraMAT CSA and InterMAT CSA in either the thigh or the calf.

Fig. 3
figure 3

Percentage changes in the IntraMAT CSA and InterMAT CSA in the thigh and calf. Values are means ± SE. InterMAT intermuscular adipose tissue

The relation between the percentage changes per day of the IntraMAT, InterMAT, and skeletal muscle tissue CSAs were estimated in the thigh and calf. The percentage change in the IntraMAT CSA in the thigh correlated significantly with that of the skeletal muscle tissue CSA (rs = −0.86, p = 0.007; Fig. 4a). We also found no significant relations for the rest of combinations, i.e., the skeletal muscle tissue CSA and the InterMAT CSA (thigh, rs = 0.36 [Fig. 4b]; calf, rs = 0.41) or the InterMAT CSA and the IntraMAT CSA (thigh, rs = −0.05 [Fig. 4c]; calf, rs = 0.69).

Fig. 4
figure 4

Relations between the changes in the IntraMAT CSA, InterMAT CSA, and skeletal muscle tissue CSA in the thigh. a IntraMAT CSA and skeletal muscle tissue CSA; b InterMAT CSA and skeletal muscle tissue CSA; c IntraMAT CSA and InterMAT CSA. IntraMAT, intramuscular adipose tissue; InterMAT, intermuscular adipose tissue; CSA, cross-sectional area

Discussion

The main findings of this study were as follows:

  1. 1.

    The skeletal muscle tissue CSA significantly decreased after 4 weeks of orthopedic treatment, whereas IntraMAT and InterMAT CSAs did not change significantly.

  2. 2.

    The percentage changes in the IntraMAT and skeletal muscle tissue CSAs among the muscle regions were not different.

  3. 3.

    There was no difference between the percentage changes in the IntraMAT and InterMAT CSAs in the thigh or calf muscles.

  4. 4.

    In the thigh, the percentage change in the IntraMAT CSA was negatively related to that of skeletal muscle tissue CSA.

The 4-week orthopedic treatment resulted in a significantly decreased skeletal muscle tissue CSA in the thigh and calf (Table 2), suggesting that skeletal muscle atrophy might be induced by CIM. We speculated that the decline in force production was due to muscle atrophy. Cook et al. [23] reported that maximum muscle strength and the CSA of the knee extensors decreased by 15.6 and 7.5% respectively, after 30 days of lower-limb unloading, implying that the decline in strength is approximately twofold greater than that of the muscle CSA, a finding similar to that reported in previous studies. Accordingly, it could be speculated that knee extension strength in our subjects might have decreased approximately 20% or more after the treatment, which would have allowed the possibility of risking gait ability dysfunction and metabolic impairment had our patients been older or suffered from diabetes or cardiovascular disease [3, 7, 8, 24]. Several reports proposed the benefit of clinical rehabilitation during orthopedic treatment. For instance, Dirks et al. [25] showed that electrical muscle stimulation prevents muscle atrophy during leg immobilization. Applying this treatment to all types of patients in that clinical situation, however, may be difficult from the viewpoint of labor, cost, and management. It is therefore necessary to introduce a way of preventing muscle atrophy during, not after, orthopedic treatment, focusing on manageability.

Compared with disuse-induced muscle atrophy, the concept of IntraMAT and InterMAT resulting from disuse has received far less attention. It is important to investigate the changes in IntraMAT and InterMAT in the clinical setting because these adipose tissues could have been negatively associated with dysfunction and metabolic changes in skeletal muscle [16, 17, 26]. Interestingly, we found that the IntraMAT and InterMAT CSAs did not change throughout the orthopedic treatment (Table 2). It has been shown that reduced muscle activity induces increased IntraMAT and InterMAT. Manini et al. [27] showed that combined IntraMAT and InterMAT volume increased by 15 and 20% in the thigh and calf, respectively, after 4 weeks of immobilization in healthy young individuals, with 0.5%–0.7% increase per day. Although our results support the reports of an IntraMAT increase with a similar rate (0.6%–1.3% per day), it did not significantly change (Figs. 2, 3). In patients 6 weeks after spinal cord injury, the IntraMAT CSA increased 126% compared with that of healthy control subjects, which corresponded to a 3.0% increase per day [10]. The increased IntraMAT CSA was three times greater in the spinal cord injury patients than in our patients. This discrepancy may be explained by the difference in the models between fracture treatment in the clinical setting and that for spinal cord injury. That is, loading was partly applied in our participants during ADLs, whereas no muscle contraction was expected in patients with a spinal cord injury. Therefore, the change in the IntraMAT CSA would depend on the type of disuse. The duration of our trial could be another key factor in interpreting the results. The average CIM duration was 26 ± 1 days in this study, which is shorter than in previous reports, in which there were statistically significant increases in IntraMAT and InterMAT [10, 27, 28]. We found only a few studies that investigated the time course of the IntraMAT increase accompanied by muscle disuse. For instance, the changes in IntraMAT in patients with a spinal cord injury were investigated on two occasions: in a patient with an injured leg 6 weeks after the injury compared with an able-bodied control leg, and in a patient with an injured leg at 6 weeks versus 18 weeks after the injury [10]. Although the increase at the first time point was 3.0% per day, that at the second time point was 0.3% per day, suggesting that the change in the IntraMAT might not be linear with the duration of disuse. Hence, the time course of changes in these adipose tissues as a result of disuse is still not well understood. Addison et al. [29] reported that the accumulation of IntraMAT was determined by several factors (i.e., age, injury, obesity, inactivity, disease). IntraMAT and InterMAT were affected by the interaction of these factors, which may be a reason why we could not confirm the changes in IntraMAT and InterMAT. We clearly showed that the changes in IntraMAT and InterMAT were negligible in this clinical trial, implying that we should carefully monitor the change in skeletal muscle tissue size rather than the fat infiltration into and between the muscles.

According to disuse and unloading studies, QF region atrophy ranged from 7 to 10% after 20 days of head-down-tilted bed rest or 20 days of unilateral limb unloading, with the degree of muscle atrophy at 0.4% to 0.5% per day [30, 31]. Their degree of atrophic response was similar to that in our study (Fig. 2). Interestingly, our group and others reported that the atrophic response is different among individual muscles in the lower limb [6, 7, 32, 33]. In this study, although the degree of reduction of the QF skeletal muscle tissue was twice as great as other lower-limb muscle regions, there was no significant difference among the muscle groups tested (Fig. 2). This finding may affect the result that the percentage change in the IntraMAT CSA was not different among the muscle groups. It was somewhat contradictory to that of Manini et al. [27], who reported an increase in the sum of the IntraMAT and InterMAT (they called it “IMAT” in their article), which was greater in the calf than in the thigh. The percentage change in the IntraMAT CSA in the anterior compartment of the calf was obviously higher than for other muscle groups, although the difference did not reach statistical significance (Fig. 2). Our participants managed the ambulatory ADLs on crutches during the treatment, with their lower limb muscles avoiding loads as much as possible. We could not completely restrict their ambulation because of a clinical observation trial, which is a limitation of this study. If the loading effect was well controlled throughout the treatment, it could provide more valuable information for estimating how much IntraMAT and skeletal muscle tissue change occurred during orthopedic treatment. It would also help when prescribing the rehabilitation program for reversing muscle atrophy and increasing IntraMAT and InterMAT.

Although we showed that the percentage changes in the IntraMAT CSA per day was approximately five times higher than that of the InterMAT CSA in the thigh, a statistically significant difference was not confirmed (Fig. 3). This result was presumed to be a large variation among individuals and a limited number of participants. IntraMAT is defined as adipose tissue infiltration into muscles or muscle groups, and InterMAT is defined as adipose tissue of the subfascia between muscles [12,13,14, 28]. It is well known that these adipose tissue types are related to the amount of visceral fat and insulin resistance [17, 18, 26]. However, the individual characteristics of these two adipose tissues have not been clarified. We further investigated the relations between the percentage changes in the IntraMAT, InterMAT, and skeletal muscle tissue CSAs in the thigh and calf (Fig. 4). As expected, although the change in the skeletal muscle tissue CSA was related to that of the IntraMAT CSA (rs = −0.86, p < 0.01), there was no significant relation to the change in the InterMAT CSA (rs = 0.36, p = 0.39) in the thigh (Fig. 4a, b). These findings indicate that IntraMAT has greater adaptive plasticity than InterMAT when there is a change in the size of the muscle, suggesting that IntraMAT could quickly fill the space left by skeletal muscle tissue that has atrophied or disappeared. However, characteristic InterMAT was less plastic than IntraMAT. In addition, we found that there was no significant correlation between the changes in the IntraMAT CSA and InterMAT CSA in the thigh and calf (thigh, rs = −0.05; calf, rs = 0.69; p > 0.05; Fig. 4c). Therefore, the adaptation to disuse is different in the IntraMAT and InterMAT CSAs, even though both are categorized as adipose tissue. Further research is needed to investigate the physiological characteristics and mechanisms of these adipose tissues.

There were some limitations to this study. First, the IntraMAT and InterMAT obtained by MRI could be affected by several factors, including daily physical activity, nutrition, and aging, among others. For instance, a previous study confirmed that energy restriction significantly decreased the IntraMAT content in middle-aged patients with type 2 diabetes, suggesting that daily food intake might be seriously related to IntraMAT and/or InterMAT [34]. We could not explore all the parameters related to lifestyle, e.g., physical activity, food intake, time to put the feet on the ground, because the participants spent their daily lives in their houses. Furthermore, the response of these adipose tissues and skeletal muscle to the orthopedic treatment would be different depending on age (the age range was 46–84 years in this study). These factors may induce the dispersion of the results within a limited number of participants (n = 8); however, this is one of the limitations of clinical experiments. We further need to investigate using a wider range of participants. Second, we did not have a control arm/group in the study. Previous studies that examined the effects of unloading or bed rest reported on before and after the thigh CSA, which consisted of IntraMAT, InterMAT, and skeletal muscle results versus those of a control. They found that the thigh CSA did not change [6, 35]. Data from a control group emphasized the effects of the clinical treatment intervention, although we observed changes in skeletal muscle tissue that were obviously decreased by physical activity, as described in previous studies. Third, we tracked only the changes in the skeletal muscle, IntraMAT, and InterMAT CSAs using pixel-by-pixel analysis on MRI scans. It would have been better to measure contractile and fat tissue via molecular levels in muscle biopsy specimens or by magnetic resonance spectroscopy. These methods, however, are invasive and costly. In addition, MRI analysis is not well established with regard to its consistency with the results of other IntraMAT and InterMAT measuring methodologies, e.g., T2 mapping, chemical-shift-based water–fat separation techniques (i.e., Dixon). Further investigation is thus needed.

In conclusion, we observed changes in thigh and calf muscle composition (i.e., IntraMAT, InterMAT, skeletal muscle tissue) during clinical orthopedic treatment (i.e., CIM with cast and crutches). Although muscle atrophy in both thigh and calf was confirmed after the treatment, the IntraMAT and InterMAT did not change. Furthermore, the percentage changes in IntraMAT and skeletal muscle tissue were not notable in thigh and calf muscle groups. These results suggest that the disuse-induced relative increase in adipose tissue that had infiltrated into the muscle (i.e., IntraMAT) was due to the decreasing skeletal muscle tissue, not an increase in adipose tissue, during the orthopedic treatment. Hence, regaining skeletal muscle tissue would be an essential treatment goal for the patients with an orthopedic injury of the lower limbs.